Literature DB >> 25631362

Home-based mindfulness therapy for lung cancer symptom management: a randomized feasibility trial.

Rebecca H Lehto1, Gwen Wyatt1, Alla Sikorskii2, Irena Tesnjak2, Vered Hankin Kaufman3.   

Abstract

Entities:  

Keywords:  Cancer; Health-related quality of life; Mindfulness Meditation; Oncology; Symptom management

Mesh：

Year:  2015        PMID： 25631362     DOI： 10.1002/pon.3755

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  5 in total

1.  Mindfulness and Meditative Movement Interventions for Men Living With Cancer: A Meta-analysis.

Authors:  C Graham Ford; Kevin E Vowles; Bruce W Smith; Anita Y Kinney
Journal:  Ann Behav Med       Date:  2020-04-20

2.  Using SMART design to improve symptom management among cancer patients: A study protocol.

Authors:  Alla Sikorskii; Gwen Wyatt; Rebecca Lehto; David Victorson; Terry Badger; Thaddeus Pace
Journal:  Res Nurs Health       Date:  2017-11-11       Impact factor: 2.228

3.  Reflexology and meditative practices for symptom management among people with cancer: Results from a sequential multiple assignment randomized trial.

Authors:  Gwen Wyatt; Rebecca Lehto; Pratim Guha-Niyogi; Sarah Brewer; David Victorson; Thaddeus Pace; Terry Badger; Alla Sikorskii
Journal:  Res Nurs Health       Date:  2021-07-19       Impact factor: 2.238

Review 4.  Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-being.

Authors:  Rebecca H Lehto
Journal:  Lung Cancer (Auckl)       Date:  2017-07-28

5.  Mindfulness Training Supports Quality of Life and Advance Care Planning in Adults With Metastatic Cancer and Their Caregivers: Results of a Pilot Study.

Authors:  Shelley A Johns; Kathleen Beck-Coon; Patrick V Stutz; Tasneem L Talib; Kelly Chinh; Ann H Cottingham; Karen Schmidt; Cleveland Shields; Madison E Stout; Timothy E Stump; Patrick O Monahan; Alexia M Torke; Paul R Helft
Journal:  Am J Hosp Palliat Care       Date:  2019-08-04       Impact factor: 2.500
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.